Let farmers decide on Bt brinjal, says Biocon chief

Image
Ramanath ShenoyPTI Bangalore
Last Updated : Jan 21 2013 | 1:47 AM IST
I / Bangalore February 5, 2010, 12:38 IST

Biotech veteran Kiran Mazumdar-Shaw has slammed attempts to politicise the Bt brinjal issue and said the decision to opt or desist from cultivating the genetically modified crop should be left to farmers.

"I have always maintained that Bt crops need to be scientifically evaluated," she said. "It is impossible to have a sensible discussion on GM crops when it is hijacked to unsubstantiated emotional levels."

The biotech major Biocon Chairman said there is a regulatory path for GM crops which aims to establish safety and efficacy over an accepted period and it has been diligently followed by Bt brinjal on the basis of which the Genetic Engineering Approval Committee (GEAC) has given its positive verdict.

"If threats and allegations reverse this verdict, it will be a regulatory failing," she said, and expressed hope that Environment Minister Jairam Ramesh takes his decision with due respect being shown to scientific evaluation and the fact that Bt brinjal "is an option, not a mandate."

"It is up to farmers to opt or desist from cultivating Bt brinjal as in the case of Bt cotton. If there are no tangible benefits, there will be no takers for Bt brinjal. Let the farmers decide," Mazumdar-Shaw suggested.

The Genetic Engineering Approval Committee had last year given the go ahead for commercialisation of Bt brinjal but has faced staiff resistance from consumer groups and NGOs.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 05 2010 | 12:38 PM IST

Next Story